If You Invested in Silexion Therapeutics Corp Warrant (SLXNW)
Looking for the current price? See the SLXNW quote & overviewWhat $1,000 or $10,000 in SLXNW Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Aug 16, 2024 |
|---|---|---|---|---|
| $1,000 | $158 -84% | — | — | $67 -93% |
| $10,000 | $1,579 -84% | — | — | $666 -93% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-10-21. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for SLXNW$1,000 Investment Over Time
SLXNW vs S&P 500Year-by-Year Returns
SLXNW annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2024 | $0.0901 | $0.0339 | -62.4% | -62.4% |
| 2025 | $0.0339 | $0.0260 | -23.3% | -71.1% |
| 2026 | $0.0260 | $0.0060 | -76.9% | -93.3% |
About Silexion Therapeutics Corp Warrant
NASDAQ
Frequently Asked Questions
Silexion Therapeutics Corp Warrant investment returns
How much would $1,000 invested in Silexion Therapeutics Corp Warrant be worth today?
If you invested $1,000 in Silexion Therapeutics Corp Warrant (SLXNW) 1 years ago on 2025-10-22, your investment would be worth $158 as of 2026-10-21, a -84.2% price return without dividends, growing at a compounded rate of -84.3% per year (CAGR).
Has Silexion Therapeutics Corp Warrant outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare SLXNW performance over available time periods.
What is Silexion Therapeutics Corp Warrant's average annual return?
The compound annual growth rate (CAGR) of SLXNW’s share price over the past 1 years is -84.3%, without dividends. Individual years vary a great deal, and SLXNW’s best recent full year was 2025 (-23.3%) while the worst was 2025 (-23.3%).
For informational and educational purposes only, not investment advice.
